Dublin, May 22, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis" report to their offering. Global Influenza Vaccine Market is worth more than US$ 5 Billion
Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is our 8th report on the Influenza Vaccine Market. This is a 383 page report with 386 Figures and 7 Tables provides data of 30 countries globally on Influenza Vaccine Market. The report provides data on Pediatrics and Adult Influenza Vaccinated Population Numbers and Market.
Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period. United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine Market Share was almost 4 times more than China and Japan Influenza Vaccine Market Share. United States & China together captures close to 60 percent in Pediatrics Influenza Vaccine Market Share. Whereas, in adult vaccination segments, United States and Japan will share more than 50 percent market share by 2022. Scope of Study: - Influenza Vaccine Market has been divided into two segments Pediatrics Influenza Vaccine Market and Adult Influenza Vaccine Market - Influenza Vaccine Market share & Forecast, Pediatrics Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast - Influenza Vaccinated Population & Forecast has been divided into two segments Pediatrics Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast - Influenza Vaccine Brand Sales and Forecast All 30 Countries have been extensively studied from 2 major points, which has been further sub-divided into 2 more points: 1. Influenza Vaccine Market & Forecast (2011 - 2022) a. Pediatrics Influenza Vaccine Market & Forecast b. Adult Influenza Vaccine Market & Forecast 2. Influenza Vaccinated Population & Forecast (2011 - 2022) a. Pediatrics Influenza Vaccinated Population & Forecast b. Adult Influenza Vaccinated Population & Forecast This report offers the best viewpoint on the leading five influenza vaccine brands: 1. Vaxigrip/Fluzone 2. Fluarix/ Flulaval 3. FluMist/Fluenz 4. Afluria/Fluvax and Fluvirin/Flucelvax 5. Anflu This report is a combination of 6 reports: 1. Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis 2. Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast 3. Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult) 4. Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination 5. Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia and Slovenia (East Europe) By (Infant & Adult) Forecast 6. Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast Key Topics Covered: 1 Executive Summary 2 Influenza - Introduction 3 Structure of Influenza Virus 4 Notable Influenza Pandemics 5 Worldwide Influenza Vaccinated Population 6 Worldwide Seasonal Influenza Vaccine Market 7 Worldwide Seasonal Influenza Vaccine Market Share Analysis 8 United States 9 Netherlands 10 Denmark 11 Estonia 12 Finland 13 Germany 14 France 15 Hungary 16 Iceland 17 Ireland 18 Italy 19 Latvia 20 Lithuania 21 Luxembourg 22 Malta 23 Norway 24 Poland 25 Portugal 26 Romania 27 Slovakia 28 Slovenia 29 Spain 30 Sweden 31 United Kingdom 32 China 33 India 34 Brazil 35 Japan 36 Australia 37 New Zealand 38 Worldwide - Seasonal Influenza Vaccine Brand Sales and Forecast 39 Seasonal Influenza Vaccine - Growth Drivers 40 Seasonal Influenza Vaccine - Challenges For more information about this report visit http://www.researchandmarkets.com/research/5t..._influenza
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Vaccines, Pediatrics
